In addition, since earlier studies on patients with breast cancer reported the role of the combination of PAK1 and CCND1 expressions as a predictor of recurrence-free survival, the relationship between PAK1 alone and the recurrence-free survival rate is unclear. This evidence concerns the gene PAK1 and breast carcinoma.